| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8818043 | Health Policy | 2017 | 9 Pages |
Abstract
As more personalized medicine and orphan drugs enter the market, registries can provide better quality evidence on their efficacy and safety. Payers need systematic assessment strategies that are communicated with more transparency. Further studies are necessary to compare the implications of different payer approaches.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Public Health and Health Policy
Authors
Irina Degtiar,